Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data

BACKGROUND: Minor histocompatibility antigens (mHA) mediate much of the graft vs. leukemia (GvL) effect and graft vs. host disease (GvHD) in patients who undergo allogeneic stem cell transplantation (SCT) [1], [2], [3], [4]. Therapeutic decision making and treatments [5] based upon mHAs will require...

Descripción completa

Detalles Bibliográficos
Autores principales: Armistead, Paul M., Liang, Shoudan, Li, Hua, Lu, Sijie, Van Bergen, Cornelis A. M., Alatrash, Gheath, St. John, Lisa, Hunsucker, Sally A., Sarantopoulos, Stefanie, Falkenburg, J. H. Frederik, Molldrem, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153501/
https://www.ncbi.nlm.nih.gov/pubmed/21858034
http://dx.doi.org/10.1371/journal.pone.0023217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153501/
https://www.ncbi.nlm.nih.gov/pubmed/21858034
http://dx.doi.org/10.1371/journal.pone.0023217

Ejemplares similares